Evidence map›Paper›PMID 31406501›Full record

ArticleChinese medicine2019

Simultaneous UPLC-TQ-MS/MS determination of six active components in rat plasma: application in the pharmacokinetic study of

Zi-Wan Ning, Li-Xiang Zhai, Jiao Peng, Ling Zhao, Tao Huang, Cheng-Yuan Lin, Wei-Hong Chen, Zhen Luo, Hai-Tao Xiao, Zhao-Xiang Bian

Open access · goldAbstract read
In one paragraph

Article in Chinese medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Activation of P2Y1R impedes intestinal mucosa repair during colitis.International journal of biological sciences · 2023
    Article
  3. Anti-Hyperglycemic Effects of Refined Fractions fromMolecules (Basel, Switzerland) · 2021
    Article
  4. Article
  5. Article
  6. Simultaneous Determination of Three Bioactive Constituents fromEvidence-based complementary and alternative medicine : eCAM · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Zi-Wan Ning1Clinical Division, School of Chinese Medicine, Hong Kong Baptist University, Baptist University Road 7, Kowloon, Hong Kong SAR China.
Li-Xiang Zhai1Clinical Division, School of Chinese Medicine, Hong Kong Baptist University, Baptist University Road 7, Kowloon, Hong Kong SAR China.
Jiao Peng2School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, 518060 China.
Ling Zhao1Clinical Division, School of Chinese Medicine, Hong Kong Baptist University, Baptist University Road 7, Kowloon, Hong Kong SAR China.
Tao Huang1Clinical Division, School of Chinese Medicine, Hong Kong Baptist University, Baptist University Road 7, Kowloon, Hong Kong SAR China.
Cheng-Yuan Lin1Clinical Division, School of Chinese Medicine, Hong Kong Baptist University, Baptist University Road 7, Kowloon, Hong Kong SAR China.
Wei-Hong ChenInfinite Chinese Herbal Immunity Research Center, Tianhe District, Guangzhou, 510000 China.
Zhen LuoInfinite Chinese Herbal Immunity Research Center, Tianhe District, Guangzhou, 510000 China.
Hai-Tao Xiao2School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen, 518060 China.
Zhao-Xiang Bian1Clinical Division, School of Chinese Medicine, Hong Kong Baptist University, Baptist University Road 7, Kowloon, Hong Kong SAR China.ORCID 0000-0001-6206-1958
Hong Kong Baptist University · HKInfinitus (China) · CNPeking University Shenzhen Hospital · CNShenzhen University Health Science Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodA sensitive, reliable, and validated ultra-performance liquid chromatography coupled with triple-quadrupole tandem mass spectrometry (UPLC-TQ-MS/MS) method was developed to simultaneously determine the presence of six active components (neochlorogenic acid, chlorogenic acid, quercetin-3-

resultThe precision, accuracy, and recovery all satisfied the criteria of international guidance (Bioanalytical Method Validation Guidance for Industry, Food and Drug Administration), and the analytes were stable in plasma for all tested conditions. The main pharmacokinetic parameters were calculated by plasma concentration versus time profiles using the pharmacokinetics program.

conclusionThe pharmacokinetic parameters of each compound can facilitate future clinical studies.

Indexed as

Cyclocarya paliurusPharmacokineticsSimultaneous determinationUPLC–TQ-MS/MS

Identifiers

PMID31406501
PMCPMC6685155
OpenAlexW2964884824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.